Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer

Alfredo Addeo(University of Geneva), Pankil Shah(The University of Texas MD Anderson Cancer Center), Natacha Bordry(University of Geneva), Robert D. Hudson(The University of Texas MD Anderson Cancer Center), Brenna Albracht(The University of Texas MD Anderson Cancer Center), Mariagrazia Di Marco(University of Geneva), Virginia Kaklamani(The University of Texas MD Anderson Cancer Center), Pierre-Yves Dietrich(University of Geneva), Barbara S. Taylor(The University of Texas at San Antonio Health Science Center), Pierre-Francois Simand(University of Geneva), Darpan I. Patel(The University of Texas MD Anderson Cancer Center), Jing Wang(The University of Texas MD Anderson Cancer Center), Sana Intidhar Labidi‐Galy(University of Geneva), Sara Fertani(University of Geneva), Robin J. Leach(The University of Texas MD Anderson Cancer Center), José Luís Sandoval(University of Geneva), Ruben A. Mesa(The University of Texas MD Anderson Cancer Center), Kate Lathrop(The University of Texas MD Anderson Cancer Center), Nicolas Mach(University of Geneva), Dimpy P. Shah(The University of Texas MD Anderson Cancer Center)
Cancer Cell
June 18, 2021
10.1016/j.ccell.2021.06.009
Cited by 242Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis